Shanghai Shen Lian Biomedical Corp
SSE:688098

Watchlist Manager
Shanghai Shen Lian Biomedical Corp Logo
Shanghai Shen Lian Biomedical Corp
SSE:688098
Watchlist
Price: 8.88 CNY 1.6% Market Closed
Market Cap: 3.6B CNY

Intrinsic Value

The intrinsic value of one Shanghai Shen Lian Biomedical Corp stock under the Base Case scenario is 14.81 CNY. Compared to the current market price of 8.88 CNY, Shanghai Shen Lian Biomedical Corp is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
14.81 CNY
Undervaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Shanghai Shen Lian Biomedical Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about Shanghai Shen Lian Biomedical Corp?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Shanghai Shen Lian Biomedical Corp valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Shanghai Shen Lian Biomedical Corp.

Explain Valuation
Compare Shanghai Shen Lian Biomedical Corp to

Fundamental Analysis

Shanghai Shen Lian Biomedical Corp
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Shanghai Shen Lian Biomedical Corp?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shanghai Shen Lian Biomedical Corp

Current Assets 542m
Receivables 307m
Other Current Assets 235m
Non-Current Assets 1B
Long-Term Investments 17m
PP&E 811m
Intangibles 137m
Other Non-Current Assets 54m
Current Liabilities 128m
Accounts Payable 9.1m
Accrued Liabilities 6.6m
Short-Term Debt 14m
Other Current Liabilities 98.3m
Non-Current Liabilities 26m
Long-Term Debt 1.4m
Other Non-Current Liabilities 24.6m
Efficiency

Free Cash Flow Analysis
Shanghai Shen Lian Biomedical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Shanghai Shen Lian Biomedical Corp

Revenue
294.1m CNY
Cost of Revenue
-123.1m CNY
Gross Profit
171m CNY
Operating Expenses
-232.3m CNY
Operating Income
-61.2m CNY
Other Expenses
15.7m CNY
Net Income
-45.6m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shanghai Shen Lian Biomedical Corp's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Low 3Y Average Net Margin
36/100
Profitability
Score

Shanghai Shen Lian Biomedical Corp's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shanghai Shen Lian Biomedical Corp's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
80/100
Solvency
Score

Shanghai Shen Lian Biomedical Corp's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shanghai Shen Lian Biomedical Corp

There are no price targets for Shanghai Shen Lian Biomedical Corp.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shanghai Shen Lian Biomedical Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Shanghai Shen Lian Biomedical Corp stock?

The intrinsic value of one Shanghai Shen Lian Biomedical Corp stock under the Base Case scenario is 14.81 CNY.

Is Shanghai Shen Lian Biomedical Corp stock undervalued or overvalued?

Compared to the current market price of 8.88 CNY, Shanghai Shen Lian Biomedical Corp is Undervalued by 40%.

Back to Top